View in EDS

Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial.
Authors: Gettinger SN; Yale Cancer Center, New Haven, Connecticut., Redman MW; SWOG Statistical Center, Seattle, Washington.; Fred Hutchinson Cancer Research Center, Seattle, Washington., Bazhenova L; University of California San Diego Moores Cancer Center, La Jolla., Hirsch FR; Mount Sinai Health System, New York, New York., Mack PC; University of California Davis Comprehensive Cancer Center, Sacramento., Schwartz LH; Columbia University Medical College, New York, New York., Bradley JD; Washington University School of Medicine, St Louis, Missouri., Stinchcombe TE; Duke University School of Medicine, Durham, North Carolina., Leighl NB; Princess Margaret Hospital, Toronto, Ontario, Canada., Ramalingam SS; Department of Hematology and Oncology, Emory University, Atlanta, Georgia., Tavernier SS; Idaho State University School of Nursing, Pocatello., Yu H; Mount Sinai Health System, New York, New York., Unger JM; SWOG Statistical Center, Seattle, Washington.; Fred Hutchinson Cancer Research Center, Seattle, Washington., Minichiello K; SWOG Statistical Center, Seattle, Washington.; Fred Hutchinson Cancer Research Center, Seattle, Washington., Highleyman L; SWOG Statistical Center, Seattle, Washington., Papadimitrakopoulou VA; The University of Texas MD Anderson Cancer Center, Houston., Kelly K; University of California Davis Comprehensive Cancer Center, Sacramento., Gandara DR; University of California Davis Comprehensive Cancer Center, Sacramento., Herbst RS; Yale Cancer Center, New Haven, Connecticut.
Source: JAMA oncology [JAMA Oncol] 2021 Sep 01; Vol. 7 (9), pp. 1368-1377.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34264316
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gettinger+SN%22">Gettinger SN</searchLink>; Yale Cancer Center, New Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Redman+MW%22">Redman MW</searchLink>; SWOG Statistical Center, Seattle, Washington.; Fred Hutchinson Cancer Research Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Bazhenova+L%22">Bazhenova L</searchLink>; University of California San Diego Moores Cancer Center, La Jolla.<br /><searchLink fieldCode="AU" term="%22Hirsch+FR%22">Hirsch FR</searchLink>; Mount Sinai Health System, New York, New York.<br /><searchLink fieldCode="AU" term="%22Mack+PC%22">Mack PC</searchLink>; University of California Davis Comprehensive Cancer Center, Sacramento.<br /><searchLink fieldCode="AU" term="%22Schwartz+LH%22">Schwartz LH</searchLink>; Columbia University Medical College, New York, New York.<br /><searchLink fieldCode="AU" term="%22Bradley+JD%22">Bradley JD</searchLink>; Washington University School of Medicine, St Louis, Missouri.<br /><searchLink fieldCode="AU" term="%22Stinchcombe+TE%22">Stinchcombe TE</searchLink>; Duke University School of Medicine, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Leighl+NB%22">Leighl NB</searchLink>; Princess Margaret Hospital, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Ramalingam+SS%22">Ramalingam SS</searchLink>; Department of Hematology and Oncology, Emory University, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Tavernier+SS%22">Tavernier SS</searchLink>; Idaho State University School of Nursing, Pocatello.<br /><searchLink fieldCode="AU" term="%22Yu+H%22">Yu H</searchLink>; Mount Sinai Health System, New York, New York.<br /><searchLink fieldCode="AU" term="%22Unger+JM%22">Unger JM</searchLink>; SWOG Statistical Center, Seattle, Washington.; Fred Hutchinson Cancer Research Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Minichiello+K%22">Minichiello K</searchLink>; SWOG Statistical Center, Seattle, Washington.; Fred Hutchinson Cancer Research Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Highleyman+L%22">Highleyman L</searchLink>; SWOG Statistical Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Papadimitrakopoulou+VA%22">Papadimitrakopoulou VA</searchLink>; The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Kelly+K%22">Kelly K</searchLink>; University of California Davis Comprehensive Cancer Center, Sacramento.<br /><searchLink fieldCode="AU" term="%22Gandara+DR%22">Gandara DR</searchLink>; University of California Davis Comprehensive Cancer Center, Sacramento.<br /><searchLink fieldCode="AU" term="%22Herbst+RS%22">Herbst RS</searchLink>; Yale Cancer Center, New Haven, Connecticut.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101652861%22">JAMA oncology</searchLink> [JAMA Oncol] 2021 Sep 01; Vol. 7 (9), pp. 1368-1377.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101652861 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2374-2445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223742437%22">23742437 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34264316
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamaoncol.2021.2209
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1368
    Titles:
      – TitleFull: Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gettinger SN
      – PersonEntity:
          Name:
            NameFull: Redman MW
      – PersonEntity:
          Name:
            NameFull: Bazhenova L
      – PersonEntity:
          Name:
            NameFull: Hirsch FR
      – PersonEntity:
          Name:
            NameFull: Mack PC
      – PersonEntity:
          Name:
            NameFull: Schwartz LH
      – PersonEntity:
          Name:
            NameFull: Bradley JD
      – PersonEntity:
          Name:
            NameFull: Stinchcombe TE
      – PersonEntity:
          Name:
            NameFull: Leighl NB
      – PersonEntity:
          Name:
            NameFull: Ramalingam SS
      – PersonEntity:
          Name:
            NameFull: Tavernier SS
      – PersonEntity:
          Name:
            NameFull: Yu H
      – PersonEntity:
          Name:
            NameFull: Unger JM
      – PersonEntity:
          Name:
            NameFull: Minichiello K
      – PersonEntity:
          Name:
            NameFull: Highleyman L
      – PersonEntity:
          Name:
            NameFull: Papadimitrakopoulou VA
      – PersonEntity:
          Name:
            NameFull: Kelly K
      – PersonEntity:
          Name:
            NameFull: Gandara DR
      – PersonEntity:
          Name:
            NameFull: Herbst RS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2021 Sep 01
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2374-2445
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: JAMA oncology
              Type: main
ResultId 1